These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7888117)

  • 1. Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions.
    Burger DM; Meenhorst PL; ten Napel CH; Mulder JW; Neef C; Koks CH; Bult A; Beijnen JH
    AIDS; 1994 Dec; 8(12):1683-9. PubMed ID: 7888117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
    Moore KH; Raasch RH; Brouwer KL; Opheim K; Cheeseman SH; Eyster E; Lemon SM; van der Horst CM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2732-7. PubMed ID: 8593010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.
    Stretcher BN; Pesce AJ; Frame PT; Greenberg KA; Stein DS
    AIDS; 1994 Jun; 8(6):763-9. PubMed ID: 8086134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.
    Barry M; Howe JL; Back DJ; Swart AM; Breckenridge AM; Weller IV; Beeching N; Nye F
    Br J Clin Pharmacol; 1994 Jan; 37(1):7-12. PubMed ID: 8148221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
    Gibb D; Barry M; Ormesher S; Nokes L; Seefried M; Giaquinto C; Back D
    Br J Clin Pharmacol; 1995 May; 39(5):527-30. PubMed ID: 7669489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.
    Schwartz EL; Brechbühl AB; Kahl P; Miller MA; Selwyn PA; Friedland GH
    J Acquir Immune Defic Syndr (1988); 1992; 5(6):619-26. PubMed ID: 1588496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients.
    Rolinski B; Bogner JR; Sadri I; Wintergerst U; Goebel FD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):192-7. PubMed ID: 9257653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
    Aweeka FT; Kang M; Yu JY; Lizak P; Alston B; Chung RT;
    HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children.
    Fauchet F; Treluyer JM; Frange P; Urien S; Foissac F; Bouazza N; Benaboud S; Blanche S; Hirt D
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4801-8. PubMed ID: 23877688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).
    McCance-Katz EF; Rainey PM; Jatlow P; Friedland G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):435-43. PubMed ID: 9715839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of zidovudine and its toxic catabolite 3'-amino-3'-deoxythymidine in HIV-infected patients.
    Zhou XJ; Sommadossi JP
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):229-33. PubMed ID: 8835201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals.
    Hurwitz SJ; Asif G; Fromentin E; Tharnish PM; Schinazi RF
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1248-55. PubMed ID: 20038617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of antineoplastic chemotherapy with zidovudine pharmacokinetics in patients with HIV-related neoplasms.
    Toffoli G; Errante D; Corona G; Vaccher E; Bertola A; Robieux I; Aita P; Sorio R; Tirelli U; Boiocchi M
    Chemotherapy; 1999; 45(6):418-28. PubMed ID: 10567772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of zidovudine after rectal administration in human immunodeficiency virus-infected patients.
    Wintergerst U; Rolinski B; Bogner JR; Notheis G; Goebel FD; Roscher AA; Belohradsky BH
    Antimicrob Agents Chemother; 1997 May; 41(5):1143-5. PubMed ID: 9145885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of high-dose zidovudine administered as a continuous infusion in patients with cancer.
    Marchbanks K; Dudley MN; Posner MR; Darnowski J
    Pharmacotherapy; 1995; 15(4):451-7. PubMed ID: 7479197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients.
    Sahai J; Gallicano K; Ormsby E; Garber G; Cameron DW
    AIDS; 1994 Jun; 8(6):793-6. PubMed ID: 8086138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated zidovudine concentrations in mononuclear cells in pediatric patients with human immunodeficiency virus infections.
    Wintermeyer SM; Nahata MC; Brady MT; Sobol BJ; Venglarcik JS 3rd ; Baker RC; Hunkler JA; McOwen NM
    Pediatr AIDS HIV Infect; 1997 Apr; 8(2):120-6. PubMed ID: 11361778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.
    Panhard X; Legrand M; Taburet AM; Diquet B; Goujard C; Mentré F;
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1019-29. PubMed ID: 17694300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of zidovudine in end-stage renal disease: influence of haemodialysis.
    Pachon J; Cisneros JM; Castillo JR; Garcia-Pesquera F; Cañas E; Viciana P
    AIDS; 1992 Aug; 6(8):827-30. PubMed ID: 1418779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.
    Morse GD; Portmore AC; Marder V; Plank C; Olson J; Taylor C; Bonnez W; Reichman RC
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.